Skip to content
Screener

Parabilis Medicines PBLS Balance Sheet Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q2 '25
$521.2M—$1.09B+1,252%——$27.71M—$80.39M—
$350.43M—$33.64M———$0———
$443K—————————
$879.02M—$1.13B———$29.36M———
$9.51M—$6.72M———$6.72M———
$1.13B—$1.18B———$80.82M———
$20.21M—$18.53M———$17.27M———
$27.3M—$31.15M———$0———
$1.25M—$5M———$12.5M———
$1.25M—$5M———$12.5M———
$68.26M—$62.84M———$56.79M———
$126.9M—$127.53M———$97.34M———
$12K—$12K———$0———
-$683.77M—-$639.28M———-$541.5M———
$1B—$1.05B+330%-$570.32M-35.3%-$526.5M-37.1%-$455.41M—
$1.13B—$1.18B———$80.82M———

FAQ

What are Parabilis Medicines's total assets?
Parabilis Medicines (PBLS) holds $1.1B in total assets.
How much debt does Parabilis Medicines have?
Parabilis Medicines carries $41.1M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.04.
How much cash does Parabilis Medicines have?
Parabilis Medicines holds $521.2M in cash and equivalents.
Can Parabilis Medicines cover its short-term obligations?
Its current ratio is 12.88 — current assets exceed current liabilities.
Where does Parabilis Medicines's balance sheet data come from?
Every line is extracted from Parabilis Medicines's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.